<DOC>
	<DOC>NCT01686061</DOC>
	<brief_summary>The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatment, and if there is any improvement in their symptoms with the treatment.</brief_summary>
	<brief_title>Blepharospasm Patient Survey for Patients With Blepharospasm</brief_title>
	<detailed_description>This study is open to males and females &gt; 18 years and &lt; 81 years with a clinical diagnosis of blepharospasm.</detailed_description>
	<mesh_term>Blepharospasm</mesh_term>
	<criteria>Male or female subject aged &gt; 18 years and &lt; 81 years Documented clinical diagnosis of blepharospasm Currently receiving incobotulinumtoxinA, abobotulinumtoxinA or onabotulinumtoxinA Previous treatment with rimabotulinumtoxinB in the last 2 treatment cycles</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>